The "North American Interventional Cardiology & Peripheral Vascular Devices Market by Angioplasty Balloon (Plain/Old, Cutting), Stent (Bioabsorbable, Drug-Eluting), Catheter (IVUS, OCT), IVC Filter (Retrievable), Endovascular Stent Graft - Forecast to 2018" analyzes and studies the major market drivers, restraints, and opportunities in the U.S. and Canada.
Browse 108 market data tables and 24 figures spread through 245 pages and in-depth TOC on "North American Peripheral Vascular Devices Market"
The North American interventional cardiology devices market is expected to reach $5,947.5 million by 2018, at a meager CAGR of 2.9%. The slow growth of this market can be attributed to the declining growth in the coronary angioplasty procedural volume (decreasing at a CAGR of around 3.0% during the forecast period) in the U.S.
Get PDF Brochure: http://www.marketsandmarkets.com/pdfdownload.asp?id=138691746
The North American interventional cardiology devices market study covers the surgical and diagnostic devices market for angioplasty, aneurysm repair, and deep vein thrombosis procedures. The devices market is further categorized into angioplasty balloons, angioplasty stents, catheters, endovascular aneurysm repair stent grafts, inferior vena cava filters, plaque modification devices, hemodynamic flow alteration devices, and accessory devices.
The bioabsorbable stents and retrievable inferior vena cava filters are expected to grow at higher CAGRs of 62.2% and 13.1%, respectively, in the coming years. The growth in the inferior vena cava filters market is primarily attributed to the rising incidence of deep vein thrombosis; whereas, lesser risk of restenosis drives the next-generation stent market. Besides surgical equipment, diagnostic catheters have also achieved market momentum over the years. The adoption of intravascular ultrasound (IVUS) and optical coherence tomography (OCT) catheters increased due to the advanced diagnosis of thrombus before angioplasty procedures.
Increasing growth in the aging population, significant increase in the number of PCI centers in the U.S., and long waiting time for care in Canada are identified as the major driving factors of the cardiac interventions market; whereas, the notable hindrance factors include declining coronary angioplasty procedures in the U.S. and conventional first level medication treatments. The rising importance of better diagnosis and increasing incidences of peripheral interventions and DVT/PE treatment procedures possess a significant growth opportunity in North America.
In 2013, Abbott Laboratories (U.S.), Cordis Corporation (U.S.), Medtronic, Inc. (U.S.), Boston Scientific Corporation (U.S.), and Covidien, Inc. (U.S.) accounted for a share of over 90%in the North American interventional cardiology devices market.
MarketsandMarkets is a global market research and consulting company based in the U.S. We publish strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies across the world.
MarketsandMarkets also provides multi-client reports, company profiles, databases, and custom research services. MarketsandMarkets covers thirteen industry verticals; including advanced materials, automotive and transportation, banking and financial services, biotechnology, chemicals, consumer goods, telecommunications and IT, energy and power, food and beverages, industrial automation, healthcare IT, medical devices, pharmaceuticals, semiconductor and electronics, aerospace & defense.
We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.
North - Dominion Plaza
17304 Preston Road
Suite 800, Dallas, TX 75252
Visit MarketsandMarkets Blog @ http://mnmblog.org/market-research/healthcare/medical-devices
Connect with us on LinkedIn @ http://www.linkedin.com/company/marketsandmarkets